Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Jan 19, 2023
MDT perspectives on the current and emerging second-line treatment options for SCLC
Thursday Jan 19, 2023
Thursday Jan 19, 2023
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team discuss the second-line treatment choices for patients with relapsed SCLC and highlight key emerging treatments and combinations in the second-line setting.
The multidisciplinary team:
- Medical oncologist: Dr Barbara Melosky, University of British Columbia, Vancouver, Canada
- Oncology pharmacist: Dr Sonia Amin Thomas, Wellstar North Fulton Hospital and Northwest Georgia Oncology Center, Roswell, GA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://www.touchrespiratory.com/cme/mdt-continuing-momentum-in-sclc-second-line-and-novel-therapies/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.